Background
==========

Enteroviruses (EVs) are among the most common human viruses infecting humans, causing a wide spectrum of illness. On the basis of phylogenetic analysis, the genus *Enterovirus* (family *Picornaviridae*) is divided into 12 species (<http://www.picornaviridae.com>). Members of human enteroviruses (HEVs) include 7 species, four HEV species and 3 recently subsumed human rhinoviruses species. Although infections caused by HEVs are often asymptomatic or mild, they can cause more severe conditions, such as neurological disease, poliomyelitis, severe neonatal systemic disease, encephalitis, meningitis, or myocarditis.

Hand, foot, and mouth disease (HFMD) is a common disease caused by HEV infection among children, particularly in those less than 5-year-old. HFMD occurs worldwide epidemically, with enterovirus 71 (EV71) and coxsackievirus A16 (CVA16) taking predominant roles in causing outbreak, while other HEV serotypes were largely associated with sporadic cases. In the past decade, the size and frequency of HFMD outbreaks have greatly increased in the Asia-Pacific region, especially in Southeast Asia \[[@B1],[@B2]\]. In China, a large scale outbreak of HFMD emerged in 2007 in Shandong Province, with 1149 cases reported \[[@B3]\]. The nationwide epidemics of HFMD started in 2008 in Anhui province, with approximately 490,000 cases reported \[[@B4]\]. Since then, there has been a large outbreak of HFMD annually in China. In 2012, the Chinese Center for Disease Control and Prevention (China CDC) confirmed 2,168,737 cases in Mainland China including 569 deaths (published on the website of the Ministry of Health of China). HFMD has become an important public health issue in China.

Since HFMD was classified as a category C notifiable infectious disease by the Ministry of Health of China in 2008, the laboratory detection of EV71 and CVA16 has been routinely performed in pediatric sentinel sites set by the Infectious Disease Surveillance Center for HFMD patients. This allowed an extensive epidemiological and genetic characterization of the EV71 and CVA16 infection nationwide. However, the negative detection of EV71 and CVA16 had been reported frequently in China \[[@B5]-[@B7]\]. In few studies, other HEV serotypes were investigated, and suggested that CVA10, CVA6, CVA4 and CVA12 were associated with sporadic HFMD cases \[[@B6],[@B7]\]. However, none of the aforementioned studies could ascertain their causal associations with HFMD development or disease severity of HFMD; due to lack of a four-fold antibody titer increase in convalescent samples, or make any comparison with healthy subjects. In addition, most previous data on HEV circulation have been reported from analysis of specimens from patients \[[@B7],[@B8]\], whereas little epidemiologic information is available for the HEV circulation in healthy population, especially in China \[[@B9]-[@B11]\]. To address this query, a designed case--control study was performed to identify the HEV circulation in children with and without HFMD. Household distribution of HEVs was also investigated to disclose the epidemiologic characteristics of household distribution of HEVs in the healthy population.

Methods
=======

Sample collection
-----------------

The case--control study was performed in Jining city in Shandong province from May to October 2010. The children diagnosed as HFMD in Jining city were recruited into the study in the sentinel hospitals set by the national surveillance program for HFMD in Shandong province. The patients were identified according to the diagnostic criteria defined by the Ministry of Health (<http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohyzs/s3586/201004/46884.htm>). Children with serious complications, including encephalitis, meningitis, acute flaccid paralysis, cardiorespiratory failure of death, were considered as severe HFMD. Children diagnosed as HFMD, but without any of the above mentioned serious complications, were classified as mild HFMD. Medical records of the HFMD patients were reviewed by physicians to collect the demographic data, the clinical symptoms and signs, laboratory findings, clinical diagnoses and outcomes.

Healthy children in Jining city were recruited as controls during the same period when the cases were recruited. Four villages that served as the sources of the patients in the selected hospitals were randomly selected as study sites. In each of two villages, one kindergarten was randomly selected to recruit healthy children less than 5-year-old. In other two villages, healthy children of less than 3-year-old were randomly recruited from families. Throat swabs were collected and personal information on demographic factors and medical history were obtained from their guardians by using a standard questionnaire. Throat swabs from parents who took care of healthy children and were willing to participate into the study in the two villages were collected simultaneously when sampling children. For the parents, personal information on demographic factors and medical history were collected via a questionnaire. All the recruited healthy children and parents did not exhibit HFMD-related symptoms before or at the time of sample collection.

This study was performed with the approval of the Ethical Committee of Beijing Institute of Microbiology and Epidemiology and Jining Infectious hospital and was conducted according to the principles expressed in the Declaration of Helsinki. At recruitment, written informed consent was obtained from all participants or guardians of pediatric participants.

Detection and genotyping of HEV
-------------------------------

For the detection of HEV, RNA were extracted from each specimen by using QIAamp® MinElute Virus Spin Kits (QIAGEN, Hilden, Germany) and the cDNA sample was synthesized by using SuperScript® III First-Strand Synthesis System for Reverse Transcription Polymerase Chain Reaction (RT-PCR) (Invitrogen, America). The detection of HEV and further classification of EV71 and CVA16 for HEV-positive samples were performed by real-time PCR using previously described primers, respectively \[[@B12]\]. To further identify the HEV serotypes other than EV71 and CVA16, semi-nested RT-PCR specific for a 5′ partial region of VP1 was performed for other HEV-positive samples by using previously reported primers \[[@B13]\]. The amplicons were subjected to sequencing and BLAST analysis.

Sequence analysis of EV71
-------------------------

The VP1 sequences (891 bp) for EV71 positive samples from healthy children and HFMD patients were amplified by nested-PCR using primers (Table [1](#T1){ref-type="table"}). The genomic sequences were assembled using Lasergene's DNA SeqMan software (version 7.1.0, DNA Star Inc. Madison, WI, USA). The sequences obtained from the study were submitted to NCBI with the GenBank Accession Numbers: KF704042-KF704050, HQ668342, HQ668360, HQ668388, HQ668400, and HQ668414-HQ668422. The MEGA program (version 5.05, Sudhir Kumar, Arizona State University) was used for alignments and phylogenetic tree construction by neighbor-joining method or maximum likelihood method with 1000 bootstrap pseudo replicates. Similarities between strains were calculated by using BioEdit (version 7.13, <http://www.mbio.ncsu.eud/bioedit/bioedit.html>).

###### 

Primers used for enterovirus 71 VP1 sequencing by RT-PCR

  **Primer**    **Sequence**                    **Position**   **Usage**
  ------------- ------------------------------- -------------- --------------------------
  VP1-2382 F1   5′-ATAATAGCACTAGCGGCAGCCCA-3′   2382           Nested RT-PCR, 1st round
  VP1-2415 F2   5′-ACCATGAAGTTGTGCAAGGA-3′      2415           Nested RT-PCR, 2st round
  VP1-3387R2    5′-GCCCCAGACTGTTGTCCAAA-3′      3387           Nested RT-PCR, 2st round
  VP1-3478R1    5′-GTCGCGAGAGCTGTCTTCCCA-3′     3478           Nested RT-PCR, 1st round
  2833F         5′-GAGYTRTTCACCTACATGCG-3′      2833           Sequencing
  3065R         5′-CTCGCRGGTGACATGAAYGG-3′      3065           Sequencing

Statistical analysis
--------------------

Descriptive statistics were performed, with continuous variables summarized as median and range, and categorical variables summarized as frequencies and proportions. The statistical significance of difference in HEV prevalence rates between various groups was tested using the *t* test for continuous variables and the *χ*^2^ test and Fisher's exact test for categorical data. Analyses were performed using SPSS, version 11.5 (SPSS).

Results
=======

Prevalence and serotypes of HEV in cases and controls
-----------------------------------------------------

Altogether 579 HFMD patients were recruited into the study, with age ranging from 4 to 97 months (median, 27.5 months) and 395 (68.2%) were males. Among all the tested HFMD patients, 440 (76.0%) were infected with HEV, among whom the frequency of HEVs in severe HFMD patients was significantly higher than that in mild disease group, 82.1% (124/151) vs. 73.8% (316/428) (*P* = 0.04). Among 440 HEV positive samples from patients, 429 were successfully typed and 12 serotypes were identified: EV71 (253, 43.7%), CVA16 (104, 18.0%), CVA10 (33, 5.7%), CVA6 (22, 3.8%), CVA12 (6, 1.0%), echovirus 9 (3, 0.5%), echovirus 6 (2, 0.4%), CVB6 (2, 0.4%), CVA4 (1, 0.2%), CVA14 (1, 0.2%), echovirus 24 (1, 0.2%) and echovirus 3 (1, 0.2%). Respectively eight and eleven serotypes were determined from severe and mild HFMD patients. The EV71 (55.0% vs. 39.7%, *P* = 0.001) and CVA16 (11.9% vs. 20.0%, *P* = 0.024) positive rate differed significantly between severe and mild HFMD patients. For the rarely detected serotypes, CVA14 was only detected from severe cases, while echovirus 3, echovirus 24, CVB6 and CVA4 were only detected from mild cases. The frequencies of other five serotypes were evenly distributed between the two groups (all *P* \> 0.05). The detailed distribution of HEV serotypes in HFMD patients is shown in Table [2](#T2){ref-type="table"}.

###### 

Prevalences of enterovirus serotypes in children with and without hand, foot, and mouth disease

                      **HFMD cases**   **Healthy children (n = 254)**   ***P*value**^**b**^          
  ------------------ ---------------- -------------------------------- --------------------- ------- ----------
  HEV status                                                                                              
   Negative             27 (17.9)                112 (26.2)                 195 (76.8)        0.04    \< 0.001
   Positive             124 (82.1)               316 (73.8)                  59 (23.2)                    
  HEV serotypes^a^                                                                                        
   EV71                 83 (55.0)                170 (39.7)                  38 (15.0)        0.001   \< 0.001
   CVA16                18 (11.9)                86 (20.0)                    7 (2.8)         0.024   \< 0.001
   CVA10                 11 (7.3)                 22 (5.1)                    2 (0.8)         0.33     0.001
   CVA6                  4 (2.7)                  18 (4.2)                    4 (1.6)         0.39      0.09
   E3                       0                     1 (0.2)                     2 (0.8)          ND       0.17
   E9                    2 (1.3)                  1 (0.2)                     1 (0.4)         0.11      0.81
   E24                      0                     1 (0.2)                     1 (0.4)          ND       0.55
   CVB6                     0                     2 (0.5)                     1 (0.4)          ND       0.91
   E6                    1 (0.7)                  1 (0.2)                        0            0.44       ND
   CVA12                 2 (1.3)                  4 (0.9)                        0            0.68       ND
   CVA4                     0                     1 (0.2)                        0             ND        ND
   CVA14                 1 (0.7)                     0                           0             ND        ND
   Untyped               2 (1.3)                  9 (2.1)                     3 (1.2)          ND        ND

^a^HFMD, hand, foot, and mouth disease; EV, enterovirus; CV, coxsackievirus; E, echovirus; NA; ND, not determined.

^b^Fisher exact test or *χ*^*2*^ test.

In total, 254 healthy children were included as control and had throat swabs collected. Their age ranged from 3 to 72 months (median: 48.0 month) and 136 (53.5%) were male. Altogether 59 (23.2%) of 254 throat swabs were found to be positive for HEV, and 56 HEV positive samples were successfully typed. Eight serotypes were determined with the most frequently presented serotypes as EV71 (38, 15.0%) and CVA16 (7, 2.8%), followed by CVA6 (4, 1.6%), CVA10 (2, 0.8%), echovirus 3 (2, 0.8%), echovirus 24 (1, 0.4%), echovirus 9 (1, 0.4%), and CVB6 (1, 0.4%).

In comparison with HFMD patients, the frequencies of HEVs in healthy controls were significantly lower, 76.0% (440/579) vs. 23.2% (59/254) (*P* \< 0.001). The EV71 (43.7% vs. 15.0%, *P* \< 0.001), CVA16 (18.0% vs. 2.8%, *P* \< 0.001), and CVA10 (5.7% vs. 0.8%, *P* = 0.001) serotypes were significantly overrepresented in HFMD cases in comparison to healthy controls. The frequencies of other five serotypes (CVA6, echovirus 3, echovirus 9, echovirus 24, CVB6) were not significantly different between the two groups (all *P* \> 0.05). Four HEV serotypes (echovirus 6, CVA12, CVA4 and CVA14) were only detected from HFMD cases, while not from healthy controls.

Prevalence and serotypes of HEV among households
------------------------------------------------

A total of 49 households involving 98 parents and 53 healthy children were recruited and sampled. The HEV infection rate for all family members was 19.2% (29/151). Children had significantly higher HEV infection rate than adults (28.3% vs. 14.3%, *P* = 0.037). The HEV infection rates were similar between mothers (12.24%; 6/49) and fathers (16.32%; 8/49) (*P* = 0.56). Twenty-two households (44.9%) had at least 1 family member with evidence of HEV infections, comprising seven serotypes: EV71 (11.92%), CVA16 (2.65%), CVA10 (1.32%), CVA6 (1.32%), echovirus 9 (0.66%), echovirus 3 (0.66%), and CVA4 (0.66%). In four households, both children and parents were infected with HEVs, although the virus serotypes involved were different within each family. The remaining 18 households had only children or parents with evidence of HEV infections. Among them, 10 households had CVA16, CVA6, E3, EV71, CVA10 infections in children, while 8 households had EV71, CVA16, CVA10, and CVA4 infections in parents (Table [3](#T3){ref-type="table"}). There were 2 households (household 44 and 45) where both father and mother had HEV infections, and the same HEV serotype (EV71) was detected between father and mother. Among 4 households which had two children, siblings were all infected with EV71 in family 37, and siblings were all negative for HEV in other 3 households (households 27, 38 and 39).

###### 

Circulation of enterovirus in healthy family members in Jining city, Shandong Province

   **No.(%) of families (n = 49)**   **HEV status**   **HEV serotypes**^**a**^                                                                                                                  
  --------------------------------- ---------------- -------------------------- ----------------- ----------------------------------------------------------------------- ---------- ---------- ----------
              27 (55.1)                 Negative              Negative                1-26                                       Negative                                  **---**    Negative   Negative
                                                                                 27 (2 children)                                 Negative                                  Negative   Negative   Negative
              10 (20.4)                 Positive              Negative                28-36        EV71 (n = 3), CVA16 (n = 2), CVA6 (n = 2), CVA10 (n = 1), E3 (n = 1),   **---**    Negative   Negative
                                                                                 37 (2 children)                                   EV71                                      EV71     Negative   Negative
              8 (16.3)                  Negative              Positive           38 (2 children)                                 Negative                                  Negative     EV71     Negative
                                                                                 39 (2 children)                                 Negative                                  Negative     EV71     Negative
                                                                                       40                                        Negative                                  **---**      CVA4     Negative
                                                                                       41                                        Negative                                  **---**    Negative     EV71
                                                                                       42                                        Negative                                  **---**    Negative     EV71
                                                                                       43                                        Negative                                  **---**    Negative     EV71
                                                                                       44                                        Negative                                  **---**      EV71       EV71
                                                                                       45                                        Negative                                  **---**      EV71       EV71
               4 (8.2)                  Positive              Positive                 46                                          EV71                                      ---       CVA10     Negative
                                                                                       47                                          CVA9                                    **---**      EV71     Negative
                                                                                       48                                          EV71                                    **---**     CVA16     Negative
                                                                                       49                                          EV71                                    **---**    Negative    CVA16

^a^EV, enterovirus; CV, coxsackievirus; E, echovirus.

Genetic characterization of EV71 circulating in healthy children and HFMD patients
----------------------------------------------------------------------------------

Among 38 EV71 positive specimens from healthy children, half (n = 19) were randomly selected and 9 entire VP1 sequences were successfully amplified and sequenced. Among 253 EV71 positive specimens from HFMD patients, 10% (n = 25) were randomly selected and 13 VP1 sequences were successfully amplified and sequenced. The failure to sequence EV71 VP1 in other specimens positive by RT-PCR may be ascribed to low viral load. The phylogenetic tree was constructed with the VP1 nucleotide sequences of both healthy children and HFMD patients from the present study and those downloaded from GenBank (Figure [1](#F1){ref-type="fig"}). All the sequenced EV71 strains in the current study were classified as belonging to the C4a group, demonstrating highest similarity with strains from Shandong province. The EV71 strains identified from healthy children and HFMD patients in this study showed sequence identity of 97.1%-100%. In addition, all isolates from members living in the same household (households 44 and 45 where both husband and wife had EV71 infection, and household 37 with all siblings infected with EV71) had 100% sequence homology, suggesting a possible interfamilial spread of this virus strain.

![**Phylogenetic trees were constructed from the VP1 nucleotide sequences of EV71 using neighbor-joining method with 1000 bootstrap by CLC genomics workbench.** The tree was based on the 891 VP1 nucleotide sequences of EV71. The strains labeled with green dots were obtained from healthy children in our study. The strains labeled with red dots were obtained from HFMD patients in our study.](1471-2334-13-606-1){#F1}

Discussion
==========

In this study, we identified a variety of HEV genotypes from throat swabs of HFMD patients in Jining, China. Our results show a diversified pathogen composition which is similar with reports from other areas of China \[[@B7],[@B14]-[@B16]\], Spain \[[@B17]\], Korea \[[@B18]\], India \[[@B19]\] and Singapore \[[@B20]\]. By comparison between HFMD cases and healthy controls, we found that EV71, CVA16, and CVA10 serotypes were more frequently related to HFMD. In contrast, other five serotypes (CVA6, echovirus 3, echovirus 9, echovirus 24, CVB6) were detected in the two groups of subjects with comparable frequency. Some HEV serotypes were only detected from HFMD cases, and not from healthy controls. However, their roles cannot be confirmed due to the small number of positives found. In this study, CVA6 was detected infrequently whereas it has been associated with sporadic HFMD cases and outbreaks occurred recently in Japan \[[@B21]\], Spain \[[@B22]\], USA \[[@B23]\] and Thailand \[[@B24]\]. A study performed in Taiwan in 2010 documented CVA6 as a major cause of atypical HFMD, while CVA16 and EV71 were reported rarely \[[@B25]\]. In addition, we found that EV71 was overrepresented in severe HFMD patients, concurring with previous studies showing extremely high circulations of EV71 in more severe cases \[[@B26]\]. Our results also supported the notion that EV71 and CVA16 circulate widely and actively in China as two main causative agents of HFMD, as previously reported \[[@B6],[@B27]\].

The aetiology of HFMD has changed with time occurred in China and in several other countries \[[@B15],[@B16],[@B24]\]. The sentinel surveillance studies performed in Linyi City, Shandong province, China, showed that the pathogen spectrum changed from 2008 to 2011, with the most prevalent HEV serotype being EV71 between 2008 to 2010, and CVA16 in 2011 \[[@B4],[@B15],[@B28]\]. CVA6 replaced CVA16 as the second most common serotype between 2010 to 2012 in Shenzhen, China \[[@B16]\]. In Thailand, HFMD is usually caused by EV71 and CVA16, but an outbreak of HFMD in 2012 was identified to be caused by CVA6 \[[@B24]\]. Considering that the population of the present study was restricted temporally and geographically, prolonged surveillance and more detailed molecular-typing surveillance of HEVs are needed to better understand the composite viral etiology of HFMD in this area.

Our understanding of epidemiological and genetic characteristics of HEV in the healthy population remains far from complete. In recent years, several studies among healthy individuals in different countries have shown diversity in HEV positive rates. Studies conducted among children in Shenzhen, China \[[@B29]\] and Norway \[[@B10],[@B30],[@B31]\] reported a HEV positive rate of 10.6 and 11.6% from stool samples respectively. Isolation rates of 64% and 35% were obtained from stool samples collected in children under 10-year-old and adults over 21-year-old in Mongolia \[[@B32]\]. With regard to EV71, diversity in positive rate has also been reported among healthy individuals in different countries. Han et al. reported positive rates of 0, 4.93 and 10.29% in throat swabs and 2.86, 3.94 and 8.82% in stools from three villages with different HFMD prevalence rate \[[@B9]\]. Studies conducted among children in Finland \[[@B33]\] and Norway \[[@B10],[@B30],[@B31]\] reported an EV71 positive rate of 0.3 and 1.4% from stool samples respectively, and isolation rate of 1.8% from stool samples were reported among children in Shenzhen, China \[[@B29]\]. Herein we demonstrated that 23.2% and 15.0% out of 254 healthy children carried HEV and EV71 respectively. This might represent the highest EV71 detection rate reported this far among healthy children. Our survey was performed during the local HFMD epidemic period ranging from May to August, which could partially explain the high EV71 frequency. The differences in specimens sampled, selection of subjects, and virus identification methods, as well as the climate, geography, crowding, and socio-economic status factors could also lead to the differences in the positive rate between our study and others.

EV71 is classified into three genotypes A, B and C, and within the genotypes B and C, there are further subgenotypes, B1-B5 and C1-C5. Recently, several studies also proposed that subgenotype C4 strains should be designated as a new genotype D and that the B5 isolates to be re-designated as B4 \[[@B34],[@B35]\]. In China, the C4 subgenotype was identified as the most prominent circulating EV71 subgenotype \[[@B27]\]. All EV71 sequences reported in this study, regardless of disease status, cluster within the C4a clade, implying that C4a EV71strains predominated in Jining city in 2010. The large numbers of asymptomatic persons who carry HEVs, especially EV71, may serve as a reservoir for transmission of HEV to children and contribute to the large epidemics that occur annually.

Transmission of HEVs within a household is common. A recent prospective family cohort study investigated EV71 patients at a children's hospital and family members of these patients who had EV71 has reported that the EV71 transmission rate to household contacts was 52%, and the transmission rate from children to parents was 41% \[[@B36]\]. Kuramitsu et al. found that interfamilial spread was responsible for 54% of non-polio HEV infections in healthy persons \[[@B32]\]. Our family study showed that 18.5% of family members were positive for HEV, and children had significantly higher HEV positive rate than adults. Limited transmission between parents and children was demonstrated, despite the inconsistent positive detection and incongruent serotypes obtained. Possible transmission between siblings and between husband and wife was suggested, however, only in few families. The information obtained in this study further supported the potential transmission of HEVs even among asymptomatic children, finally leading to a high reservoir for future epidemic. Our study findings stress the importance of personal hygiene to prevent infection with HEVs in the home environment. However, because of the limited number of families, further studies of larger sample size are needed. In addition, prospective follow-up of households would help clarify the distribution and transmission of HEVs within a household.

Conclusions
===========

In conclusion, this study demonstrated the co-circulation of multiple HEV serotypes in both HFMD cases and healthy children during HFMD epidemics. This study provides useful epidemiological data on the features of the spread of HEV among families as well. These findings have important public health implication for HFMD control, especially in HFMD high epidemic regions.
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